Acorah Software Products - Accounts Production 16.2.850 false true 29 February 2024 1 March 2023 false 1 March 2024 28 February 2025 28 February 2025 12474118 Dr Smeer Aggarwal iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12474118 2024-02-29 12474118 2025-02-28 12474118 2024-03-01 2025-02-28 12474118 frs-core:CurrentFinancialInstruments 2025-02-28 12474118 frs-core:ComputerEquipment 2025-02-28 12474118 frs-core:ComputerEquipment 2024-03-01 2025-02-28 12474118 frs-core:ComputerEquipment 2024-02-29 12474118 frs-core:FurnitureFittings 2025-02-28 12474118 frs-core:FurnitureFittings 2024-03-01 2025-02-28 12474118 frs-core:FurnitureFittings 2024-02-29 12474118 frs-core:ShareCapital 2025-02-28 12474118 frs-core:RetainedEarningsAccumulatedLosses 2025-02-28 12474118 frs-bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 12474118 frs-bus:FilletedAccounts 2024-03-01 2025-02-28 12474118 frs-bus:SmallEntities 2024-03-01 2025-02-28 12474118 frs-bus:AuditExempt-NoAccountantsReport 2024-03-01 2025-02-28 12474118 frs-bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 12474118 frs-core:ListedExchangeTraded 2025-02-28 12474118 frs-core:ListedExchangeTraded 2024-02-29 12474118 frs-core:CostValuation frs-core:ListedExchangeTraded 2024-02-29 12474118 frs-core:AdditionsToInvestments frs-core:ListedExchangeTraded 2025-02-28 12474118 frs-core:DisposalsRepaymentsInvestments frs-core:ListedExchangeTraded 2025-02-28 12474118 frs-core:RevaluationsIncreaseDecreaseInInvestments frs-core:ListedExchangeTraded 2025-02-28 12474118 frs-core:CostValuation frs-core:ListedExchangeTraded 2025-02-28 12474118 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2024-02-29 12474118 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2025-02-28 12474118 frs-bus:Director1 2024-03-01 2025-02-28 12474118 frs-bus:Director1 2024-02-29 12474118 frs-bus:Director1 2025-02-28 12474118 frs-countries:EnglandWales 2024-03-01 2025-02-28 12474118 2023-02-28 12474118 2024-02-29 12474118 2023-03-01 2024-02-29 12474118 frs-core:CurrentFinancialInstruments 2024-02-29 12474118 frs-core:ShareCapital 2024-02-29 12474118 frs-core:RetainedEarningsAccumulatedLosses 2024-02-29
Registered number: 12474118
SKA Medical Services Limited
Unaudited Financial Statements
For The Year Ended 28 February 2025
Sharpe Medical Accounting Ltd
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 12474118
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 5,407 6,423
Investments 5 163,546 150,789
168,953 157,212
CURRENT ASSETS
Debtors 6 7,473 9,394
Cash at bank and in hand 147,468 60,116
154,941 69,510
Creditors: Amounts Falling Due Within One Year 7 (51,853 ) (29,309 )
NET CURRENT ASSETS (LIABILITIES) 103,088 40,201
TOTAL ASSETS LESS CURRENT LIABILITIES 272,041 197,413
NET ASSETS 272,041 197,413
CAPITAL AND RESERVES
Called up share capital 8 100 100
Profit and Loss Account 271,941 197,313
SHAREHOLDERS' FUNDS 272,041 197,413
Page 1
Page 2
For the year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr Smeer Aggarwal
Director
18/07/2025
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
SKA Medical Services Limited is a private company, limited by shares, incorporated in England & Wales, registered number 12474118 . The registered office is Normanby Gateway, Lysaghts Way, Scunthorpe, DN15 9YG.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is recognised when a company gains entitlement to receive income from a third party.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures & Fittings 20% on WDV
Computer Equipment 33% Straight line
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
Page 3
Page 4
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Tangible Assets
Fixtures & Fittings Computer Equipment Total
£ £ £
Cost
As at 1 March 2024 - 9,873 9,873
Additions 1,214 863 2,077
As at 28 February 2025 1,214 10,736 11,950
Depreciation
As at 1 March 2024 - 3,450 3,450
Provided during the period 50 3,043 3,093
As at 28 February 2025 50 6,493 6,543
Net Book Value
As at 28 February 2025 1,164 4,243 5,407
As at 1 March 2024 - 6,423 6,423
5. Investments
Listed
£
Cost
As at 1 March 2024 150,789
Additions 163,875
Disposals (173,616 )
Revaluations 22,498
As at 28 February 2025 163,546
Provision
As at 1 March 2024 -
As at 28 February 2025 -
Net Book Value
As at 28 February 2025 163,546
As at 1 March 2024 150,789
Page 4
Page 5
6. Debtors
2025 2024
£ £
Due within one year
Prepayments and accrued income 338 338
Director's loan account 7,135 9,056
7,473 9,394
7. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors - 2
Bank loans and overdrafts 32 32
Corporation tax 47,424 28,257
Other creditors 3,318 -
Accruals and deferred income 1,079 1,018
51,853 29,309
8. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 100 100
9. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 March 2024 Amounts advanced Amounts repaid Amounts written off As at 28 February 2025
£ £ £ £ £
Dr Smeer Aggarwal 9,056 8,511 10,430 - 7,137
The above loan is unsecured, interest free and repayable on demand.
Page 5